Lantheus Holdings, Inc.

Industry

  • Services
  • In Vitro Diagnostics
    • Saliva-based Testing
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
    • Specialty Pharmaceuticals
  • Digital Health
    • Disease Management
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Ultrasound
      • Molecular Imaging
      • Digital Imaging
      • MRI, NMR

Other Names/Subsidiaries

  • Cerveau Technologies
  • Lantheus Medical Imaging
  • Meilleur Technologies
  • Progenics Pharmaceuticals
See more in Biomedtracker

Latest on Lantheus Holdings, Inc.

Scrip

ITM Plots Logistics In GEP-NETs Ahead Of Drug Filing After Phase III Success

 
• By Alaric DeArment

ITM Isotope Technologies Munich is preparing the complex logistics and manufacturing it will need for commercial launch of ITM-11 (non-carrier-added 177 Lu-edotreotide), its radiopharmaceutical candid

Scrip

Deal Watch: Novo Nordisk, IMMvention To Partner On Sickle Cell Disease

 
• By Joseph Haas, Dexter Jie Yan, Xu Hu, and Vibha Ravi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novo Nordisk, IMMvention Collaboration

Scrip

Deal Watch: Bausch Companies Set Hectic Pace At J.P. Morgan With Five Deals

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. B+L Bolsters Ophthalmology With Acquis

Scrip

Deal Watch: Regeneron Quietly Acquires UK Ophthalmology Firm Oxular

 
• By Joseph Haas and Dexter Jie Yan

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Regeneron Bolsters Ophthalmic Portfoli